Actavis acquires Allergan for $66 billion

Actavis acquires Allergan for $66 billion

Actavis acquires Allergan for $66 billion

Actavis announced on Monday to acquire Allergan for 219 per share in cash and Actavis shares – total valued $66 billion.

“This combination will greatly enhance our U.S. and international commercial opportunities,” said Paul Bisaro, executive chairman of Actavis.

The combined company will be led by Brent Saunders, President and CEO of Actavis. Paul Bisario remains Executive chairman of Actavis.

Allerganhas spent six months defending against a takeover by Valeant and Ackman. Pyott told shareholders would be hurt because of Valeant’s cost-cutting, it could be to stop its growth and Valeant’s accounting, which is examined Valeant’s accounting.

Valeant Chairman and CEO J. Michael Pearson said in a statement that his firm “cannot justify to its own shareholders paying a price of $219 or more per share for Allergan.”

“Today’s transaction provides Allergan stockholders with substantial and immediate value, as well as the opportunity to participate in the significant upside potential of the combined company,” David E. I. Pyott, chairman and CEO of Allergan, said in a statement.

 Allergan shares rose up 6.6 percent to $211.

Mr. Stakebay says:

The combined company will have expecting $23 billion in revenue and both companies made commitment to development and research and donate about $1.7 billion every year.


Chairman and CEO of Allergan……..David E. I. Pyott……….(1998-present)……$ 12 029 283 (2013)

CEO and President of Actavis………Brent L. Saunders…….(2013-present)……..$ 8 860 000 (2013)




$ 8.677 billion (2013)

$ 6.3 Billion (2013)

Operating income

$ – 423. 2 million (2013)

$ 1.809 Billion (2013)


$ – 750.4 billion (2013)

$ 985.1 Million (2013)

Total assets

$ 22.725 billion (2013)

$ 10.574 Billion (2013)

Total Equity

 $ 9.537 billion (2013)

$6.469 Billion (2013)


19200 (2013)

10800 (2013)


You Might Also Like

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>